Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-17T23:17:08.694Z Has data issue: false hasContentIssue false
  • English
  • Français

Improvement of facial affect recognition in children and adolescents with attention-deficit/hyperactivity disorder under methylphenidate

Published online by Cambridge University Press:  13 November 2013

Sophie Beyer von Morgenstern ,
Ingrid Becker  and
Judith Sinzig
Sophie Beyer von Morgenstern*
Affiliation:
Department for Paediatric Surgery, Children's Hospital Dritter Orden, Munich, Germany
Ingrid Becker
Affiliation:
Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Germany
Judith Sinzig
Affiliation:
Department for Child and Adolescent Psychiatry and Psychotherapy, LVR Hospital Bonn, Bonn, Germany
*
S Beyer von. Morgenstern, Department for Child and Adolescent Psychiatry and Psychotherapy, University of Cologne, Munich, Germany. Tel: +49-163-2611986; E-mail: sophiemorgenstern@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction and Hypothesis

Some authors draw a connection between the dopaminergic pathways and emotional perception. The present study is based on that association and addresses the question whether methylphenidate and the resulting amelioration of the disturbed dopamine metabolism lead to an improvement of the facial affect recognition abilities in children with attention-deficit/hyperactivity disorder (ADHD).

Methods

A computer test was conducted on 21 participants, aged 7–14 years and with a diagnosis of ADHD – some with comorbid oppositional defiant disorder – conducted the FEFA (Frankfurt Test and Training of Facial Affect), a computer test to examine their facial affect recognition abilities. It consists of two subtests, one with faces and one with eye pairs. All participants were tested in a double-blind cross-over study, once under placebo and once under methylphenidate.

Results and Discussion

The collected data showed that methylphenidate leads to amelioration of facial affect recognition abilities, but not on a significant level. Reasons for missing significance may be the small sample size or the fact that there exists some overlapping in cerebral connections and metabolic pathways of the site of action of methylphenidate and the affected dopaminergic areas in ADHD. However, consistent with the endophenotype concept, certain gene locations of the dopaminergic metabolism as both an aetiological factor for ADHD and the deficient facial affect recognition abilities with these individuals were considered. Consulting current literature they were found to be not concordant. Therefore, we conclude that the lacking significance of the methylphenidate affect on facial affect recognition is based on this fact.

Keywords

ADHDaffect recognitionfacial affect recognitionmethylphenidate
Type
Original Articles
Information
Acta Neuropsychiatrica , Volume 26 , Issue 4 , August 2014 , pp. 202 - 208
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Scheres, A, Oosterlaan, J, Swanson, J et al. The effect of methylphenidate on three forms of response inhibition in boys with AD/HD. J Abnorm Child Psychol 2003;31:105–120.CrossRefGoogle ScholarPubMed
2. World Health Organisation. International Classification of Diseases, 10th Revision. Chapter V, Mental and Behavioral Disorders, 1992.Google Scholar
3. Huss, M, Hölling, H, Kurth, B-M, Schlack, R. How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS). Eur Child Adolesc Psychiatry 2008;17:52–58.CrossRefGoogle ScholarPubMed
4. Ramtekkar, UP, Reiersen, AM, Todorov, AA, Todd, RD. Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry 2010;49:217–228.Google ScholarPubMed
5. Skounti, M, Philalithis, A, Galanakis, E. Variations in prevalence of attention deficit hyperactivity disorder worldwide. Eur J Pediatr 2007;166:117–123.CrossRefGoogle ScholarPubMed
6. Premack, D, Woodruff, G. Does the chimpanzee have a theory of mind? Behav Brain Sci 1978;4:515–526.CrossRefGoogle Scholar
7. Baron-Cohen, S, Jolliffe, T, Mortimore, C, Robertson, M. Another advanced test of theory of mind: evidence from very high functioning adults with autism or Asperger syndrome. J Child Psychol Psychiatry 1997;38:813–822.CrossRefGoogle ScholarPubMed
8. Humphreys, K, Minshew, N, Leonard, GL, Behrmann, M. A fine-grained analysis of facial expression processing in high-functioning adults with autism. Neuropsychologia 2007;45:685–695.CrossRefGoogle ScholarPubMed
9. Buitelaar, JK, van der Wees, M, Swaab-Barneveld, H, van der Gaag, RJ. Theory of mind and emotion-recognition functioning in autistic spectrum disorders and in psychiatric control and normal children. Dev Psychopathol 1999;11:39–58.CrossRefGoogle ScholarPubMed
10. Sinzig, J, Morsch, D, Lehmkuhl, G. Do hyperactivity, impulsivity and inattention have an impact on the ability of facial affect recognition in children with autism and ADHD? Eur Child Adolesc Psychiatry 2008;17:63–72.CrossRefGoogle ScholarPubMed
11. Kats-Gold, I, Besser, A, Priel, B. The role of simple emotion recognition skills among school aged boys at risk of ADHD. J Abnorm Child Psychol 2007;35:363–378.CrossRefGoogle ScholarPubMed
12. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073–1086.CrossRefGoogle Scholar
13. Gatley, SJ, Pan, D, Chen, R, Chaturvedi, G, Ding, Y-S. Affinities of methylphenidate derivates for dopamine, norepinephrine and serotonin transporters. Life Sci 1996;58:231–239.CrossRefGoogle ScholarPubMed
14. Kuczenski, R, Segal, DS. Effects of methyiphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison, with amphetamine. J Neurochem 1997;68:2032–2037.CrossRefGoogle ScholarPubMed
15. Volkow, ND, Wang, G-J, Fowler, JS et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. Journal Neurosci 2001;21:1–5.CrossRefGoogle ScholarPubMed
16. Rubia, K, Halari, R, Cubillo, A, Mohammad, A-M, Brammer, M, Taylor, E. Methylphenidate normalises activation and functional connectivity deficits inattention and motivation networks in medication-naive children with ADHD during a rewarded continuous performance task. Neuropharmacology 2009;57:640–652.CrossRefGoogle Scholar
17. Salgado-Pineda, P, Delaveau, P, Blin, O, Nieoullon, A. Dopaminergic contribution to the regulation of emotional perception. Clin Neuropharmacol 2005;28:228–237.CrossRefGoogle Scholar
18. Boelte, S, Feineis-Matthews, S, Leber, S, Dierks, T, Hubl, D, Poustka, F. The development and evaluation of a computer-based program to test and to teach the recognition of facial affect. Int J Circumpolar Health 2002;61(Suppl. 2):61–68.Google Scholar
19. Jones, B, Kenward, MG. Design and Analysis of Cross-over-Trials, 2nd edn. Chapman & Hall/CRC, Boca Raton, Florida, 2003.CrossRefGoogle Scholar
20. Williams, LM, Hermens, DF, Palmer, D et al. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects. Biol Psychiatry 2008;63:917–926.CrossRefGoogle ScholarPubMed
21. McAlpine, C, Singh, NN, Kendall, KA, Ellis, CR. Recognition of facial expressions of emotion by persons with mental retardation: a matched comparison study. Behav Modif 1992;16:543–558.CrossRefGoogle ScholarPubMed
22. Zhu, B, Chen, C, Moyzis, RK et al. Genetic variations in the dopamine system and facial expression recognition in healthy Chinese college students. Neuropsychobiology 2012;65:83–89.CrossRefGoogle ScholarPubMed
23. Borod, JC, Koff, E, Perlman Lorch, M, Nicholas, M. The expression and perception of facial emotion in brain-damaged patients. Neuropsychologia 1986;24:169–180.CrossRefGoogle ScholarPubMed
24. Bowers, D, Blonder, LX, Feinberg, T, Heilman, KM. Differential impact of right and left hemisphere lesions on facial emotion and object imagery. Brain 1991;114:2593–2609.CrossRefGoogle ScholarPubMed
25. Harciarek, M, Heilman, KM. The contribution of anterior and posterior regions of the right hemisphere to the recognition of emotional faces. J Clin Exp Neuropsychol 2009;31:322–330.CrossRefGoogle Scholar
26. Ludolph, AG, Kassubek, J, Schmeck, K et al. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F.fluorophenyl-L-alanine PET study. NeuroImage 2008;41:718–727.CrossRefGoogle ScholarPubMed
27. Huck, NO, McBridge, SA, Kendall, AP, Grugle, NL, Killgore, WDS. The effects of modafinil, caffeine and dextroamphetamine on judgements of simple versus complex emotional expressions following sleep deprivation. Int J Neurosci 2008;118:487–502.CrossRefGoogle ScholarPubMed
28. Lackner, C, Sabbagh, MA, Hallinan, E, Liu, X, Holden, JJA. Dopamine receptor D4 gene variation predicts preschoolers’ developing theory of mind. Dev Sci 2012;15:272–280.CrossRefGoogle ScholarPubMed
29. Faraone, SV, Doyle, AE, Mick, E, Biederman, J. Meta-analysis of the association between the 7-repeat allele of the dopamine D4 receptor gene, and attention deficit hyperactivity disorder. Am J Psychiatry 2001;158:1052–1057.CrossRefGoogle ScholarPubMed
30. Grady, DL, Harxhi, A, Smith, M et al. Sequence variants of the DRD4 gene in autism: further evidence that rare DRD4 7R haplotypes are ADHD specific. Am J Med Genet B (Neuropsychiatr Genet) 2005;136B:33–35.CrossRefGoogle ScholarPubMed
31. Flint, J, Munafò, MR. The endophenotype concept in psychiatric genetics. Psychol Med 2007;37:163–180.CrossRefGoogle ScholarPubMed
32. Gottesman, II, Gould, TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636–645.CrossRefGoogle ScholarPubMed
33. Zobel, A, Maier, W. Endophänotypen – ein neues Konzept zur biologischen Charakterisierung psychischer Störungen. Nervenarzt 2004;75:205–221.CrossRefGoogle Scholar
34. Abu-Akel, A. The neurochemical hypothesis of ‘theory of mind’. Med Hypotheses 2003;60:382–386.CrossRefGoogle ScholarPubMed
35. Breuer, D, Doepfner, M. Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen bei Drei- bis Sechsjährigen in der ärztlichen Praxis – eine bundesweite Befragung. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 2006;34:357–365.CrossRefGoogle Scholar